Tag: NeuroPace

neuropace NIH

New data demonstrates “unprecedented” efficacy outcomes with the NeuroPace RNS system

NeuroPace has announced that new data from a multicentre, real-world clinical study of the RNS system has demonstrated outcomes never before seen with other...

NIH study to utilise NeuroPace RNS system for research on the...

NeuroPace has announced that the company’s RNS  system, a closed-loop neuromodulation technology approved to treat adults with medically refractory focal onset epilepsy, will be...

NeuroPace present positive data from studies of the RNS System

NeuroPace has presented long-term clinical results demonstrating that the RNS System for refractory epilepsy significantly reduces seizure frequency in patients, with one in three...

NeuroPace announces new Category I CPT code for the RNS system

NeuroPace has announced that the American Medical Association (AMA) has issued a new Category I Current Procedural Terminology (CPT) code for electrocorticography from an implanted...

NeuroPace launches next generation RNS system, the world’s only brain-computer interface...

NeuroPace has announced the launch of its Next Gen RNS System for the treatment of refractory epilepsy. The RNS System is a type of...

NeuroPace closes US$74 million equity funding to accelerate commercialisation of epilepsy...

NeuroPace has closed a US$74 million round of funding led by the KCK Group and OrbiMed Advisors. This funding provides the resources necessary to...